Julie Hamburg is the Director of Patient Advocacy for Guardant Health, a precision oncology company. Prior to joining Guardant, Julie worked at Pfizer, where she managed their prescription assistance programs and helped patients navigate access and affordability challenges.
Throughout her career, Julie has worked to advocate for patients’ needs. In 2017, that work became personal, when Julie’s daughter, Lila, was diagnosed with SATB2-associated syndrome (SAS). Julie is excited to bring her love of advocacy and communications to the SATB2 Gene Foundation to build further awareness, connections, and support for those impacted by SAS, and to ensure their collective voice is heard.
Julie holds a BA in Psychology from the University of Virginia and a Master’s in Public Health from Columbia University.